TY - JOUR
T1 - Chromosomal imbalances in malignant peripheral nerve sheath tumor detected by metaphase and microarray comparative genomic hybridization
AU - Nakagawa, Yasuko
AU - Yoshida, Aki
AU - Numoto, Kunihiko
AU - Kunisada, Toshiyuki
AU - Wai, Daniel
AU - Ohata, Norihide
AU - Takeda, Ken
AU - Kawai, Akira
AU - Ozaki, Toshifumi
PY - 2006/2
Y1 - 2006/2
N2 - Malignant peripheral nerve sheath tumors (MPNSTs) are highly malignant tumors affecting adolescents and adults. There have been a few reports on chromosomal aberrations of MPNSTs; however, the tumor-specific alteration remains unknown. We characterized the genomic alterations in 8 MPNSTs and 8 schwannomas by metaphase comparative genomic hybridization (CGH). In 5 of 8 MPNSTs, microarray CGH was added for more detailed analyses. Frequent gains were identified on 3q13-26, 5p13-14, and 12q11-23 and frequent losses were at 1p31, 10p, 11q24-qter, 16, and 17. Microarray CGH revealed frequent gains of EGFR, DAB2, MSH2, KCNK12, DDX15, CDK6, and LAMA3, and losses of CDH1, GLTSCR2, EGR1, CTSB, GATA3, and SULT2A1. These genes seem to be responsible for developing MPNSTs. The concordance rate between metaphase CGH and microarray CGH was 66%. Metaphase CGH was useful for identifying chromosomal alterations before applying microarray CGH.
AB - Malignant peripheral nerve sheath tumors (MPNSTs) are highly malignant tumors affecting adolescents and adults. There have been a few reports on chromosomal aberrations of MPNSTs; however, the tumor-specific alteration remains unknown. We characterized the genomic alterations in 8 MPNSTs and 8 schwannomas by metaphase comparative genomic hybridization (CGH). In 5 of 8 MPNSTs, microarray CGH was added for more detailed analyses. Frequent gains were identified on 3q13-26, 5p13-14, and 12q11-23 and frequent losses were at 1p31, 10p, 11q24-qter, 16, and 17. Microarray CGH revealed frequent gains of EGFR, DAB2, MSH2, KCNK12, DDX15, CDK6, and LAMA3, and losses of CDH1, GLTSCR2, EGR1, CTSB, GATA3, and SULT2A1. These genes seem to be responsible for developing MPNSTs. The concordance rate between metaphase CGH and microarray CGH was 66%. Metaphase CGH was useful for identifying chromosomal alterations before applying microarray CGH.
KW - Chromosomal imbalances
KW - Genomic hybridization
KW - Microarray
KW - Nerve sheath tumor
UR - http://www.scopus.com/inward/record.url?scp=33646753630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646753630&partnerID=8YFLogxK
U2 - 10.3892/or.15.2.297
DO - 10.3892/or.15.2.297
M3 - Article
C2 - 16391845
AN - SCOPUS:33646753630
SN - 1021-335X
VL - 15
SP - 297
EP - 303
JO - Oncology Reports
JF - Oncology Reports
IS - 2
ER -